This inventor holds 1 USPTO granted patent. Top assignee: Roussel Uclaf. Active years: 1983.
Company Filing History:
Years Active: 1983
Title: The Innovative Contributions of Rene Heyles
Introduction
Rene Heyles is a notable inventor based in Romainvill, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotic compounds. Her work has led to the creation of innovative derivatives that hold promise for medical applications.
Latest Patents
Rene Heyles holds a patent for "Novel 3-acetoxymethyl-7-(iminoacetamido)-cephalosporanic acid derivatives." This patent describes compounds of the formula ##STR1##, wherein R is selected from the group consisting of hydrogen and groups easily removable by acid hydrolysis or hydrogenolysis. R' is selected from the group consisting of hydrogen, alkyl of 1 to 4 carbon atoms, alkenyl and alkynyl of 2 to 4 carbon atoms, and groups easily removable by acid hydrolysis or hydrogenolysis. A is selected from the group consisting of hydrogen, alkali metal, and equivalents of an alkaline earth metal or magnesium and an organic amine base. The compounds have antibiotic activity and a process for their preparation.
Career Highlights
Rene Heyles has had a distinguished career, working at Roussel Uclaf, a prominent pharmaceutical company. Her research and development efforts have contributed to advancements in antibiotic therapies, showcasing her expertise in the field.
Collaborations
Rene collaborates with Andre Lutz, who is also involved in the pharmaceutical sector. Their partnership has fostered innovation and the development of new compounds that may enhance treatment options in medicine.
Conclusion
Rene Heyles is a pioneering inventor whose work in antibiotic compounds has the potential to impact healthcare significantly. Her contributions to the field exemplify the importance of innovation in pharmaceuticals.